Tunbridge W M, Brewis M, French J M, Appleton D, Bird T, Clark F, Evered D C, Evans J G, Hall R, Smith P, Stephenson J, Young E
Br Med J (Clin Res Ed). 1981 Jan 24;282(6260):258-62. doi: 10.1136/bmj.282.6260.258.
One hundred and sixty-three asymptomatic people with thyroid antibodies or raised serum thyrotrophin (TSH) concentrations, or both, and 209 age-matched and sex-matched controls without either marker of thyroid disorder were followed up for four years to determine the natural history of autoimmune thyroiditis. Mildly raised TSH concentrations alone and the presence of thyroid antibodies alone did not significantly increase the risk of developing overt hypothyroidism during the four years compared with the controls. Overt hypothyroidism developed at the rate of 5% a year in women who initially had both raised TSH concentrations and thyroid antibodies. Prophylactic treatment with thyroxine may be justified in women found to have both markers of impending thyroid failure. The cost effectiveness of screening the adult population remains to be evaluated.
163名甲状腺抗体阳性或血清促甲状腺激素(TSH)浓度升高或两者皆有的无症状人群,以及209名年龄和性别匹配且无任何甲状腺疾病标志物的对照人群,接受了为期四年的随访,以确定自身免疫性甲状腺炎的自然病程。与对照组相比,仅TSH浓度轻度升高和仅存在甲状腺抗体在四年中并未显著增加发生明显甲状腺功能减退的风险。最初TSH浓度升高且存在甲状腺抗体的女性中,明显甲状腺功能减退的发生率为每年5%。对于发现有即将发生甲状腺功能减退的两种标志物的女性,使用甲状腺素进行预防性治疗可能是合理的。对成年人群进行筛查的成本效益仍有待评估。